Clinical Microbiology and Infection

Article	Citations
Cefiderocol for resistant Gram negatives: linking in vitro activity with clinical effectiveness	262
‘Scope and aims of ESCMID guidelines’ by Scudeller et al.	206
Re: Diagnostic limitations and challenges in current clinical guidelines and potential application of metagenomic sequencing to manage pulmonary invasive fungal infections in patients with haematologi	152
Re: ‘The relative effectiveness of a high-dose quadrivalent influenza vaccine versus standard-dose quadrivalent influenza vaccines in older adults in France: a retrospective cohort study during the 20	147
Re: ‘Association between pertactin-producing Bordetella pertussis and fulminant pertussis in infants: a multicentre study in France, 2008–2019’ by Leroux et al.	139
Primary antifungal prophylaxis after haematopoietic stem cell transplantation: will the search for perfection become the enemy of good?	128
Which trial do we need? Doxycycline in combination with ceftriaxone for the treatment of community-acquired pneumonia	122
Outside Front Cover	120
COVID-19 in special populations	113
Re: what is the role of epidemiological investigations in human Campylobacter outbreaks in the One Health and whole-genome sequencing era in Denmark?	112
Has the COVID-19 pandemic wiped out the seasonality of outpatient antibiotic use and influenza activity? A time-series analysis from 2014 to 2021	110
Re: ‘Dosing and route of administration of clindamycin given in combination with rifampicin’ by Magreault et al.	110
The diagnostic value of serum Borrelia burgdorferi antibodies and seroconversion after Lyme neuroborreliosis, a nationwide observational study	107
Should multiplex PCR testing be integrated into antimicrobial stewardship programs for paediatric community-acquired pneumonia in the emergency department?	98
Assessment of BIV1-CovIran inactivated vaccine–elicited neutralizing antibody against the emerging SARS-CoV-2 variants of concern	95
Limitations of genomic surveillance: a Clostridioides difficile case study in the Netherlands	91
Resistance mutations in SARS-CoV-2 omicron variant in patients treated with sotrovimab	89
Acute cough in outpatients: what causes it, how long does it last, and how severe is it for different viruses and bacteria?	86
TMPRSS2 inhibitors for the treatment of COVID-19 in adults: a systematic review and meta-analysis of randomized clinical trials of nafamostat and camostat mesylate	83
How to: Diagnose inborn errors of intrinsic and innate immunity to viral, bacterial, mycobacterial, and fungal infections	83
Risk of major structural birth defects following repeat mRNA COVID-19 vaccination in the first trimester: a population-based cohort study	82
Delayed intestinal adenovirus response to intravenous brincidofovir in paediatric allogeneic stem cell transplant recipients displaying rapid clearance of the virus from peripheral blood	78
Large language models for antibiotic prescribing—moving the needle from ‘parlour trick’ to practical tool	77
A randomized trial of simultaneous versus sequential pneumococcal vaccination in elderly	76
European society of clinical microbiology and infectious diseases guidelines for antimicrobial stewardship in emergency departments (endorsed by European association of hospital pharmacists)	72

Optimising the management of invasive candidiasis	71
What is the evidence base of used aggregated antibiotic resistance percentages to change empirical antibiotic treatment? A scoping review	71
Measuring the impact of hospitalization for infectious diseases on the quality of life of older patients in four European countries: the AEQUI longitudinal matched cohort study (2020–2023)	68
Expected phenotypes and expert rules are important complements to antimicrobial susceptibility testing	68
The interplay between Epstein-Barr virus and cytomegalovirus reactivation following allogeneic haematopoietic cell transplantation in the era of primary cytomegalovirus prophylaxis	66
Fecal pharmacokinetics/pharmacodynamics characteristics of fidaxomicin and vancomycin against Clostridioides difficile infection elucidated by in vivo feces-based infectious evaluation models	65
The importance of patient information and informed consent for unlicensed phage therapy	64
Pathogen and host determinants of extrapulmonary tuberculosis among 1035 patients in Frankfurt am Main, Germany, 2008–2023	63
Myxovirus resistance protein A for discriminating between viral and bacterial lower respiratory tract infections in children – The TREND study	62
Exploring the limits of interferon-γ releasing assay screening in large-scale populations	62
A phase Ib, placebo-controlled randomized clinical trial of the Ebolavirus DNA vaccine candidate INO-4201 followed by electroporation as booster vaccination in healthy, rVSVΔG-ZEBOV-GP-primed voluntee	62
‘Introducing new antibiotics for multidrug-resistant bacteria: obstacles and the way forward’ – author's response	61
Antimicrobial susceptibility of Mycobacterium abscessus and treatment of pulmonary and extra-pulmonary infections	61
Optimizing antifungal therapies for Candida infections: evidence, resistance, and emerging approaches	58
Acquired fluconazole resistance and genetic clustering in Diutina (Candida) catenulata from clinical samples	57
‘Early antifungal prophylaxis fails to prevent influenza-associated pulmonary aspergillosis in the ICU’– Author’s reply	56
Pharmacokinetics/pharmacodynamics of phage therapy: a major hurdle to clinical translation	56
Antibiotic resistance associated with the COVID-19 pandemic: a systematic review and meta-analysis	56
Re: Compromised access to antibiotics: addressing paediatric challenges in availability and responsible use	55
Respiratory syncytial virus in adults with comorbidities: an update on epidemiology, vaccines, and treatments	52
Effects of azithromycin and doxycycline on the vaginal microbiota of women with urogenital Chlamydia trachomatis infection: a substudy of the Chlazidoxy randomized controlled trial	51
Re: ‘Heightened incidence of adverse events associated with a live attenuated varicella vaccine strain that lacks critical genetic polymorphisms in ORF62’ by Kim et al.	51
Developing tailored dosing recommendations for ciprofloxacin in critically ill children using a population approach based on total and unbound concentrations	50
A comparative evaluation of commercial boric acid containers for preserving microorganisms in urine specimens	50
Detection of fungal pathogens by a histomolecular approach using targeted-massive parallel sequencing on formalin-fixed tissues: a retrospective study	48
Optimization of antiviral dosing in Herpesviridae encephalitis: a promising approach to improve outcome?	48
Which trial do we need? Combination treatment of Pneumocystis jirovecii pneumonia in non-HIV infected patients	47
Which trial do we need? Three-day course of antibiotics for acute pyelonephritis in immunocompetent women	47
The hidden link between cefiderocol resistance and increased virulence in Klebsiella pneumoniae: insights from a transposon-directed insertion-site sequencing-based investigation	47
Which trial do we need? Next-generation sequencing to individualize therapy in Staphylococcus aureus bacteraemia	47
One- versus two-specimen Xpert strategy to discontinue airborne isolation in suspected pulmonary tuberculosis: systematic review and meta-analysis	47
Which trials do we need?	47
Uncovering hidden transmission pathways of Klebsiella pneumoniae: is there a need to re-evaluate the necessity for toilet disinfection?	46
Steroids for viral meningitis: a foe or a friend?	46
The controversial bond between COVID-19 and bacterial superinfections	44
Safety of pertussis vaccination in pregnancy and effectiveness in infants: a Danish national cohort study 2019–2023	43
Evaluating stratified T-SPOT.TB results for diagnostic accuracy in tuberculosis disease: a retrospective cohort study with sensitivities, specificities, and predictive values	43
Pertussis upsurge, age shift and vaccine escape post-COVID-19 caused by ptxP3 macrolide-resistant Bordetella pertussis MT28 clone in China	43
Scope and aims of European society of clinical microbiology and infectious diseases guidelines: a white paper	43
Effect of antiseptic bathing with chlorhexidine or octenidine on central line–associated bloodstream infections in intensive care patients: a cluster-randomized controlled trial	43
Respiratory multiplex PCR and procalcitonin to reduce antibiotic exposure in severe SARS-CoV-2 pneumonia: a multicentre randomized controlled trial	43
Remdesivir for the treatment of COVID-19: author's response	42
Assessing prescription of antibiotics after vaccination against pneumococcal pneumonia; using prescription sequence symmetry analysis	42
A strain uncoloured by Gram staining in a pleural fluid	42
Seeing is Believing	42
A chronic infectious bladder stone causing an obstructive emphysematous cystitis	42
Oral step-down with β-lactams for uncomplicated Enterobacterales bacteraemia	41
Diagnostic accuracy of self-collected tongue swabs for Mycobacterium tuberculosis complex detection in individuals being assessed for tuberculosis in South Africa using the Xpert MTB/RIF Ultra assay	41
Community adoption of protective behaviours: before and during the COVID-19 pandemic	41
The disease burden of Delta and Omicron variants of severe acute respiratory syndrome coronavirus 2 in a predominantly vaccinated and healthy cohort	40

Inferring antibiotic susceptibility from metagenomic data: dream or reality?	40
Pharmacokinetic and pharmacodynamic evaluations of oral moxifloxacin for Enterococcus faecalis endocarditis	40
Antimicrobial stewardship during extracorporeal membrane oxygenation: challenges and new perspectives	40
Methenamine hippurate as prophylaxis for recurrent urinary tract infections in older women—a triple-blind, randomised, placebo-controlled, phase IV trial (ImpresU)	40
Evaluating the lockdown-induced effect on respiratory viruses in blood donors during two COVID-19 waves: a retrospective cross-sectional observational study in Denmark	39
Rectal colonization by multidrug-resistant Gram-negative bacteria and subsequent bacteraemia in haematological patients	38
Unexpected natural cefiderocol resistance in Stenotrophomonas maltophilia associated to the genogroup 4 genetic background	38
Anti-SARS-CoV-2 antibody response after 2 and 3 doses of BNT162b2 mRNA vaccine in patients with lymphoid malignancies	38
Biofilm formation on endovascular aneurysm repair (EVAR) grafts—a proof of concept in vitro model	38
Detection of viable SARS-CoV-2 in retrospective analysis of aerosol samples collected from hospital rooms of patients with COVID-19	38
Effect of a multimodal prevention strategy on dialysis-associated infection events in outpatients receiving haemodialysis: The DIPS stepped wedge, cluster-randomized trial	38
Removal of incorrect penicillin allergy labels in a UK hospital	37
Alternative therapies against Mycobacterium abscessus infections	37
Comparing large language models for antibiotic prescribing in different clinical scenarios: which performs better?	36
Which trial do we need? Combination antimicrobial therapy for hospital-acquired bacterial pneumonia caused by Pseudomonas aeruginosa	36
Infectious encephalitis among adults: a prospective and population-based cohort study	36
A multiserological line assay to potentially discriminate current from past Helicobacter pylori infection	36
The emergence of a multidrug resistant Salmonella Muenchen in Israel is associated with horizontal acquisition of the epidemic pESI plasmid	35
Laboratory innovations to diagnose invasive mould infections—what is relevant, what is not?	35
Real-world effectiveness of nirmatrelvir/ritonavir against COVID-19 hospitalizations and severe COVID-19 in community-dwelling elderly Singaporeans during Omicron BA.2, BA.4/5, and XBB transmission	35
Kinetics of the Alethia® malaria loop-mediated isothermal amplification (LAMP) positivity during post-treatment follow-up of patients with imported malaria	35
Microbiome science at a turning point: from descriptive ecology to clinical decision making in infectious diseases	35
Women's acceptance of two strategies for preventing respiratory syncytial virus infant bronchiolitis: maternal immunization or monoclonal antibodies for newborns	35
Aspergillus and host-pathogen interaction: focus on treatment-relevant aspects	34
Which trial do we need? A pragmatic randomized trial of trimethoprim-sulfamethoxazole vs. vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteraemia in low-resource settin	34
Changing face of mpox	34
Tackling clinical research fragmentation in public health emergencies in Europe	33
Variability of interferon-γ release assays in people at high risk of tuberculosis infection or progression to tuberculosis disease living in the United States	33
Using a difficult-to-treat resistance index to gauge imbalance between countries' antibiotic resistance prevalence and access to antibiotics: a scoping review and concept proposal	33
A systematic review of antibiotic drug shortages and the strategies employed for managing these shortages	33
Lumbar-sacral giant sparganosis presenting as an intradural mass	33
Real-life validation of a sample pooling strategy for screening of hepatitis C	32
Assessing the accuracy of a novel algorithm for group B Streptococcus detection in pregnant women and its impact on early-onset neonatal group B streptococcal infections	32
Greater attention to flexible hospital designs and ventilated clinical facilities are a pre-requisite for coping with the next airborne pandemic	32
‘Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM’ – Author's reply	32
Using machine learning to predict antibody response to SARS-CoV-2 vaccination in solid organ transplant recipients: the multicentre ORCHESTRA cohort	32
Re: ‘ESCMID guidelines on diagnosis and treatment of brain abscess in children and adults’ by Bodilsen et al.	32
Immunologic characterization of a patient with clinical and virologic rebound upon Nirmatrelvir/Ritonavir treatment: the unfortunate epilogue of COVID-19	32
Alcaligenes faecalis metallo-β-lactamase in extensively drug-resistant Pseudomonas aeruginosa isolates	32
New drugs, old problems: a narrative review of antibiotic stewardship programme in the era of novel gram-negative antibiotics	31
Decision letters from other journals	31
Are we enrolling the right patients? A scoping review of external validity and generalizability of clinical trials in bloodstream infections	31
Which trial do we need? Corticosteroid therapy in Lyme borreliosis–associated facial palsy: a double-blind placebo-controlled multicentre randomized trial	31
Clinical microbiology and infection supports early-career researchers	31
An introduction to network meta-analyses in clinical microbiology and infectious diseases	31
Ampicillin susceptibility testing of Haemophilus influenzae in the routine clinical laboratory by the EUCAST methodology compared to broth microdilution and the presence of ftsI gene mutations	31
High SARS-CoV-2 seroprevalence among health care workers in Bamako referral hospitals: a prospective multisite cross-sectional study (ANRS COV11)	31
Rice bodies in Brucellar tenosynovitis	30
Factors associated with SARS-CoV-2 testing, diagnosis and COVID-19 disease among individuals prescribed opioid-agonist treatment: a nationwide retrospective cohort study	30
Matrix Assisted Laser Desorption Ionisation/Time Of Flight (MALDI/TOF) mass spectrometry is not done revolutionizing clinical microbiology diagnostic	30
Predictors of laboratory-confirmed mpox in people with mpox-like illness	30
Revisiting diagnostics: practical application of next-generation sequencing technologies for infectious diseases	30
Testing guidelines during times of crisis: challenges and limitations of developing rapid and living guidelines	30
Late positivization of oropharyngeal, plasma, anal, semen, and urine specimens which tested negative at the time of mpox diagnosis	30
Inappropriate use of ivermectin during the COVID-19 pandemic: primum non nocere!	30
Carbapenem-resistant Enterobacterales acquisition following piperacillin-tazobactam versus carbapenem treatment: a propensity-matched cohort study	29
Towards a Europe-wide reconstruction and analysis of hospital networks	29
Neisseria meningitidis MenY ST-1466 harbouring Neisseria gonorrhoeae 16S rRNA allele causing false-positive Aptima® gonococcal nucleic acid amplification test results	29
Why don't we talk about tuberculosis stewardship?	29
Blood culture bottles remain efficient months after their expiration date: implications for low- and middle-income countries	29
Early switch to oral antimicrobials in brain abscess: a narrative review	28
Performance of whole genome sequencing for respiratory syncytial virus: insights from the first external quality assessment, France, 2024	28
Revisiting diagnostics: progress, gaps, and the road ahead	28
‘Neurodevelopmental outcomes of infants after in utero exposure to SARS-CoV-2 or mRNA COVID-19 vaccine compared to unexposed infants’ – author's response	28
Aspergillus-specific IgG antibodies for diagnosing chronic pulmonary aspergillosis compared to the reference standard	27
How to use direct microscopy for diagnosing fungal infections	27
An overview of COVID-19 in solid organ transplantation	27
Availability and costs of medicines for the treatment of tuberculosis in Europe	27
Macrolide therapy in Pseudomonas aeruginosa infections causes uL4 ribosomal protein mutations leading to high-level resistance	27
Exploring the dynamics of Borrelia burgdorferi sensu lato antibodies—a registry-based study on laboratory data from Sweden and Denmark	27
PD-1 blockade and lenalidomide combination therapy for chronic active Epstein-Barr virus infection	26
Bacillus Calmette-Guérin vaccine to reduce healthcare worker absenteeism in COVID-19 pandemic, a randomized controlled trial	26
Relative contributions of the ERG11VF125AL and MRR1AN647T mutations to fluconazole resistance in Clade III Candidozyma (Candida) auris clinical isolates	26
The path ahead: building community between palliative care and infectious disease teams	26
How to perform pharmacokinetic research of antimicrobial drugs in critically ill patients undergoing continuous renal replacement therapy: a scoping review of all relevant pharmacokinetic factors	26
How to interpret MICs of amphotericin B, echinocandins and flucytosine against Candida auris (Candidozyma auris) according to the newly established European Committee for Antimicrobial Susceptibility	26
Diagnostic test accuracy of the Fungitell serum (1→3)-β-D-glucan assay for the diagnosis of Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis	26
Risk of congenital malformation after first trimester mRNA COVID-19 vaccine exposure in pregnancy: the COVI-PREG prospective cohort	26
Funguria with severe complications in diabetic patients receiving SGLT2 inhibitors	25
Population pharmacokinetics of polymyxin B: an individual participant data meta-analysis	25

Integrating pre-test probability and β-D-glucan cut-offs to enhance accuracy in diagnosing pneumocystis pneumonia	25
SARS-CoV-2 exposures of healthcare workers from primary care, long-term care facilities and hospitals: a nationwide matched case-control study	25
Diagnostic value of maternal, cord blood and neonatal biomarkers for early-onset sepsis: a systematic review and meta-analysis	25
Re: ‘Unexpected increase of severe Mycoplasma pneumoniae pneumonia in adults in Southern Switzerland’ by Garzoni et al.	25
Seeing the whole elephant: designing ‘one health’ governance to fight antimicrobial resistance	25
Long-term evolution of humoral immune response after SARS-CoV-2 infection	25
Dual β-lactam therapy to improve treatment outcome in Mycobacterium abscessus disease	25
COVID-19 vaccine: missed opportunities and hospital vaccine implementation	25
Prophylactic anticoagulation with low molecular weight heparin in COVID-19: cohort studies in Denmark and Sweden	25
ΔF659 and F659S substitutions at the HS1 of FKS2 gene, along with E655A and W715L upstream and downstream substitutions, correlate with high ibrexafungerp MICs against Candida glabrata	24
Oral antiviral drugs for treatment of cytomegalovirus in transplant recipients	24
Escherichia coli community-acquired meningitis in adults: a case series of 29 patients in France	24
Sepsis: a summary of the SEP-1 quality measure and future considerations	24
Colistin plus meropenem versus colistin alone for invasive infections caused by carbapenem-resistant Acinetobacter baumannii: a rapid systematic review of randomized controlled trials using Bayesian m	24
Vaccination against SARS-CoV-2 in pregnancy during the Omicron wave: the prospective cohort study of the Italian obstetric surveillance system	24
Re: predictors and microbiology of respiratory and bloodstream infection in patients with COVID-19	24
Re: ‘Nirmatrelvir/ritonavir treatment and risk for post-acute sequelae of COVID-19 infection in older Singaporeans’ by Wee et al.	24
Bordetella pertussis isolates in Finland after acellular vaccination: serotype change and biofilm formation	24
Target trial emulation framework: mitigating methodological challenges and application in COVID-19 treatment evaluation studies	24
Re: ‘Which trial do we need? Combination treatment of Pneumocystis jirovecii pneumonia in non-HIV infected patients’ by Cornely et al.	24
Determining the effect of pneumococcal vaccination on antibiotic prescriptions: is prescription sequence symmetry analysis a valid approach?	24
Risk of Helicobacter pylori transmission by faecal microbiota transplantation via oral capsules	24
First-generation oral antivirals against SARS-CoV-2	23
Ceftaroline for methicillin-resistant Staphylococcus aureus bacteraemia: a magic bullet, a weight on the seesaw, or neither?	23
Association between β-lactam exposure and clearance of bacteraemia and acute kidney injury in patients with methicillin-resistant Staphylococcus aureus bloodstream infections—a post hoc analysis of th	23
Reunion's bold bet against leptospirosis	23
Cefazolin vs. antistaphylococcal penicillins for the treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a systematic review and meta-analysis	23
Efficacy of extended infusion of β-lactam antibiotics for the treatment of febrile neutropenia in haematologic patients (BEATLE): a randomized, multicentre, open-label, superiority clinical trial	23
Kinetics of the humoral and cellular immune response up to 1 year from mpox virus infection	23
Management of Gram-positive multiresistant bacteria prosthetic joint infection: a narrative review on current and innovative strategies	23
Corrigendum to “A new SARS-CoV-2 variant with high lethality poorly detected by RT-PCR on nasopharyngeal samples: an observational study” [Clin Microbiol Infect 28 (2) (2022) 298.e9–e15]	23
Genomic determinants of Bacillus cereus and outcomes of infection in preterm neonates: a multicentre retrospective study	22
Effect of adequacy of empirical antibiotic therapy for hospital-acquired bloodstream infections on intensive care unit patient prognosis: a causal inference approach using data from the Eurobact2 stud	22
Clinical characteristics and outcomes of Bordetella parapertussis compared with Bordetella pertussis: a retrospective observational study	22
Bidirectional associations between bacteremia and cytomegalovirus infection after allogeneic hematopoietic cell transplantation: JSTCT Transplant Complications Working Group	22
Pleural aspergillosis in an otherwise healthy patient diagnosed by medical thoracoscopy	22
A contemporary review of clade-specific virological differences in monkeypox viruses	22
Establishing piperacillin–tazobactam susceptibility in ceftriaxone non-susceptible Enterobacterales: comparing disk diffusion, Etest, and VITEK 2 automated minimal inhibitory concentration measurement	22
How to: the application and analysis of categorical agreement in antimicrobial susceptibility testing using European Committee on Antimicrobial Susceptibility Testing breakpoints	22
Mortality and sequelae associated with regional use of intracranial devices among patients with pneumococcal meningitis: a nationwide, population-based cohort study	22
Corrigendum to “Does SARS-CoV-2 re-infection depend on virus variant?” [Clin Microbiol Infect 27 (9) (2021 Sep) 1374–1375]	21
Early and better diagnosis for Lyme neuroborreliosis	21
HlyF, an underestimated virulence factor of uropathogenic Escherichia coli	21
Validation and prognostic utility of a definition of uncomplicated Gram-negative bloodstream infection	21
Septic pubic symphysitis: newest radiological, microbiological, and outcome findings in a rare and difficult-to-treat infection	21
Epidemiology of genital human papillomavirus infections in sequential male sex partners of young females	21
Comparing large language models for antibiotic prescribing in different clinical scenarios: author's response	21
Corrigendum to “Biofilm formation on endovascular aneurysm repair (EVAR) grafts—a proof of concept in vitro model” [Clin Microbiol Infect 29 (12) (2023) P1600.e1–1600.e6]	21
Impact of vaccination on the symptoms of hospitalised patients with SARS-CoV-2 Delta variant (B.1.617.1) infection	21
Re: ‘Aspergillus-specific IgG antibodies for diagnosing chronic pulmonary aspergillosis compared to the reference standard’ by Salzer et al.	21
Neonatal sepsis: a complex high-impact global health challenge urgently requiring prioritization	21
Which trial do we need? Plasma metagenomic next-generation sequencing to diagnose infections in patients with haematological malignancies and febrile neutropenia: proposal for a randomized-controlled	21
Enhancing antimicrobial stewardship: recommendations to support implementation of the 2024 UN General Assembly political declaration on antimicrobial resistance	21
Decision letter from other journals and peer review	20
Co-administration of COVID-19 and influenza vaccines	20
Antibiotic resistance in Türkiye: what has been done and what needs to be done urgently?	20
Massive furunculoid myiasis in a traveller after a trip to Uganda	20
Cerebrospinal fluid galactomannan detection for the diagnosis of central nervous system aspergillosis: a diagnostic test accuracy systematic review and meta-analysis	20
Safeguarding COVID-19 vaccines: establishing the safety of novel vaccine platforms	20
Executive Committee	20
Association of time to positivity with disease severity in bloodstream infections—a population-based cohort study	20
Case-fatality rate of invasive pneumococcal disease caused by various serotypes—an analysis of nationwide surveillance data from Israel, 2009–2018	20
Predicting critical illness on initial diagnosis of COVID-19 based on easily-obtained clinical variables: author's response	20
Refocus attention on HIV/AIDS: due to neglect during the COVID-19 pandemic	20
Which trial do we need? Aminopenicillin-gentamicin versus aminopenicillin-ceftriaxone for Enterococcus faecalis endocarditis	20
Passive surveillance of Powassan virus in human-biting ticks and health outcomes of associated bite victims	19
Bacteriophage therapy in humans	19
Human alveolar echinococcosis–global, regional, and national annual incidence and prevalence rates	19
Benznidazole therapy is cost-saving compared with no treatment for indeterminate chronic Chagas disease in the Spanish healthcare setting	19
Role of the gut microbiome in shaping drug response in immunocompromised hosts	19
Lower (1,3)-beta-d-glucan sensitivity and in vitro levels in Candida auris and Candida parapsilosis strains	19
Re: ‘ESCMID clinical guidelines on the evaluation and management of a reported antibiotic allergy’ by Joean et al.	19
Immunogenicity of Omicron BA.1-adapted BNT162b2 vaccines: randomized trial, 3-month follow-up	19
Comparative epidemiology of diarrhoeal organisms in high-risk adults using multiplex PCR gastrointestinal panel testing: a multicentre observational study	19
Impact of meningococcal ACWY conjugate vaccines on pharyngeal carriage in adolescents: evidence for herd protection from the UK MenACWY programme	19
Confront cholera crisis after the Myanmar earthquake	19
New antifungals for the treatment of invasive mould disease	19
Threshold protective levels of serum IgG to Shigella lipopolysaccharide: re-analysis of Shigella vaccine trials data	19
How to set up and manage a microbiome research facility	19
Addressing vaccine hesitancy in health care workers promotes public vaccination	19
Borrelia mayonii – A cause of Lyme borreliosis that can be visualized by microscopy of thin blood films	18
Methods for determining indications for antibiotic prescriptions to facilitate antimicrobial stewardship: a scoping review	18
Sore throat-related infections – lessons learnt from non-pharmacological interventions and non-COVID-19 infections	18
Real-world clinical outcome of cefiderocol for treatment of multidrug-resistant non-fermenting, gram negative bacilli infections: a case series	18
Evaluation of droplet digital polymerase chain reaction by detecting cell-free deoxyribonucleic acid in pleural effusion for the diagnosis of tuberculous pleurisy: a multicentre cohort study	18
An unusual paediatric case of post–kala-azar dermal leishmaniasis: a hidden parasite under the veil of white	18
Inborn errors of immunity underlying a susceptibility to pyogenic infections: from innate immune system deficiency to complex phenotypes	18
The clinical significance of Dientamoeba fragilis and Blastocystis in human stool—retrospective cohort study	18
The challenge to improving and standardizing training in infectious diseases in Europe	18
Effect of SARS-CoV-2 infection and pandemic period on healthcare-associated infections acquired in intensive care units	17
Diagnostic accuracy of rapid one-step PCR assays for detection of herpes simplex virus-1 and -2 in cerebrospinal fluid: a systematic review and meta-analysis	17
Tocilizumab versus baricitinib in hospitalized patients with severe COVID-19: an open label, randomized controlled trial	17
Clinical consequences of very major errors with semi-automated testing systems for antimicrobial susceptibility of carbapenem-resistant Enterobacterales	17
Evaluation of a multiplex PCR assay using barcoded magnetic bead technology for detection of fungal pathogens in bronchoalveolar lavage fluid	17
Modifiable and nonmodifiable risk factors for non-ventilator-associated hospital-acquired pneumonia identified in a retrospective cohort study	17